Publications by authors named "Matthew French-Kim"

Claim this Profile
T
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination.
Spyridoula Vasileiou, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Mansi Narula, Matthew French-Kim

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Matthew French-Kim

Ther Adv Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
Premal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, George Carrum, Carlos A Ramos, Matthew French-Kim

Sci Transl Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Study of Warfarin Genotyping in the VACHS Affiliated Anticoagulation Clinic of Puerto Rico.
Carlos Martes-Martinez, Cristian Méndez-Sepúlveda, Joel Millán-Molina, Matthew French-Kim, Heriberto Marín-Centeno

P R Health Sci J· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis